SQZ Biotechnologies Operating Income 2020-2023 | SQZ
SQZ Biotechnologies operating income from 2020 to 2023. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
SQZ Biotechnologies Annual Operating Income
(Millions of US $) |
| 2022 |
$-81 |
| 2021 |
$-69 |
| 2020 |
$-51 |
| 2019 |
$-34 |
SQZ Biotechnologies Quarterly Operating Income
(Millions of US $) |
| 2023-03-31 |
$-18 |
| 2022-12-31 |
$-14 |
| 2022-09-30 |
$-23 |
| 2022-06-30 |
$-23 |
| 2022-03-31 |
$-21 |
| 2021-12-31 |
$-12 |
| 2021-09-30 |
$-22 |
| 2021-06-30 |
$-19 |
| 2021-03-31 |
$-15 |
| 2020-12-31 |
$-18 |
| 2020-09-30 |
$-12 |
| 2020-06-30 |
$-10 |
| 2020-03-31 |
$-11 |
| 2019-12-31 |
|
| 2019-09-30 |
$-8 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$0.018B |
$0.021B |
|
SQZ Biotechnologies Company is a clinical-stage biotechnology company. It develops transformative cell therapies for patients with cancer, infectious diseases and other serious conditions. The company's prime product candidate consist SQZ-PBMC-HPV which is in clinical stage. SQZ Biotechnologies Company is based In Watertown, Massachusetts.
|
